Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Related Articles by Review for PubMed (Select 23194346)

1.
2.

The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant.

Modlin IM, Moss SF, Gustafsson BI, Lawrence B, Schimmack S, Kidd M.

Langenbecks Arch Surg. 2011 Dec;396(8):1145-56. doi: 10.1007/s00423-011-0794-7. Epub 2011 Apr 27. Review.

PMID:
21523447
3.

Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.

Singh S, Law C.

Expert Rev Gastroenterol Hepatol. 2012 Jun;6(3):313-34. doi: 10.1586/egh.12.15. Review.

PMID:
22646254
4.

Neuroendocrine neoplasms of the gastrointestinal tract.

Schott M, Klöppel G, Raffel A, Saleh A, Knoefel WT, Scherbaum WA.

Dtsch Arztebl Int. 2011 May;108(18):305-12. doi: 10.3238/arztebl.2011.0305. Epub 2011 May 6. Review.

5.

Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.

Anlauf M.

Horm Metab Res. 2011 Nov;43(12):825-31. doi: 10.1055/s-0031-1291307. Epub 2011 Nov 21. Review.

PMID:
22105474
6.

Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.

Klöppel G.

Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S1-16. doi: 10.1530/ERC-11-0013. Print 2011 Oct. Review.

7.

Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature.

Abdel-Rahman O, Fouad M.

J Cancer Res Clin Oncol. 2015 Feb;141(2):295-305. doi: 10.1007/s00432-014-1757-5. Epub 2014 Jul 3. Review.

PMID:
24990591
8.

[Neuroendocrine tumors of the kidney: report of 3 cases and review of the literature].

XIA Q, LIU DG, Jiang WQ.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 Mar;31(3):548-50. Review. Chinese.

9.

Neuroendocrine tumor disease: an evolving landscape.

Frilling A, Akerström G, Falconi M, Pavel M, Ramos J, Kidd M, Modlin IM.

Endocr Relat Cancer. 2012 Sep 14;19(5):R163-85. doi: 10.1530/ERC-12-0024. Print 2012 Oct. Review.

10.

[Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].

Szczeblowska D.

Pol Merkur Lekarski. 2007 May;22(131):437-41. Review. Polish.

PMID:
17679390
11.

Surgical treatment of gastrointestinal neuroendocrine tumors.

Fendrich V, Bartsch DK.

Langenbecks Arch Surg. 2011 Mar;396(3):299-311. doi: 10.1007/s00423-011-0741-7. Epub 2011 Feb 1. Review.

PMID:
21279821
12.

[Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].

Langfort R, Rudziński P, Burakowska B.

Pneumonol Alergol Pol. 2010;78(1):33-46. Review. Polish.

13.

Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Klöppel G, Rindi G, Anlauf M, Perren A, Komminoth P.

Virchows Arch. 2007 Aug;451 Suppl 1:S9-27. Epub 2007 Aug 8. Review.

PMID:
17684761
14.

Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors.

Lindholm DP, Oberg K.

Horm Metab Res. 2011 Nov;43(12):832-7. doi: 10.1055/s-0031-1287794. Epub 2011 Oct 18. Review.

PMID:
22009449
15.

Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours.

Tomassetti P, Migliori M, Lalli S, Campana D, Tomassetti V, Corinaldesi R.

Ann Oncol. 2001;12 Suppl 2:S95-9. Review.

PMID:
11762360
16.

Biochemical diagnosis of neuroendocrine GEP tumor.

Oberg K.

Yale J Biol Med. 1997 Sep-Dec;70(5-6):501-8. Review.

17.

Gastroenteropancreatic neuroendocrine tumors: update on therapeutics.

Ganetsky A, Bhatt V.

Ann Pharmacother. 2012 Jun;46(6):851-62. doi: 10.1345/aph.1Q729. Epub 2012 May 15. Review.

PMID:
22589450
18.

The p53 network as therapeutic target in gastroenteropancreatic neuroendocrine neoplasms.

Briest F, Grabowski P.

Cancer Treat Rev. 2015 May;41(5):423-430. doi: 10.1016/j.ctrv.2015.03.006. Epub 2015 Mar 21. Review.

PMID:
25837868
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk